Search

You searched for "MMC"

286 results found

Specialty doctor interviews

1 February 2019 | | Ophthalmology
I started my training as an ophthalmologist in the Wild West of Carmarthenshire where I did my first laser procedure, first phacoemulsification and first slit-lamp examination. All of these firsts were done under the tutelage of very skilled staff grade...

A short survey of the views of clinicians on the role of procedure-specific consent forms

1 October 2018 | | Ophthalmology
Informed consent is an ethical and legal right of every patient [1]. It is essential that patients receive clear, concise and accurate information regarding the risks, benefits and alternatives to a potential intervention. In addition to this, the patient must...

Optometrist found guilty of manslaughter

1 December 2016 | Optometry
To start our new Optometry section, editor Janet Pooley takes a look at the tragic death of Vincent Barker and asks what lessons can be learned. In August, Optometrist Honey Rose was found guilty of the manslaughter of eight-year-old Vincent...
Case Reports in Ophthalmology cover image

Retinal vascular occlusion from gentamicin injection post-vitrectomy

4 February 2021 | | Retina / Uvea / Vitreous | Gentamicin, Macular ischemia, Retinal vascular occlusion, Vitrectomy
The authors present two case reports for the rare, but serious, complication of retinal vascular occlusion as a presumed result of subconjunctival injection following 25-gauge vitrectomy. Risk factors for the complication include: cardiovascular disease, retrobulbar anaesthesia, high intraocular pressure (IOP)...

5-FU vs. Avastin as adjunct to conjunctival autograft

1 October 2016 | | Cornea / External Eye Disease
The authors compare the outcome of pterygium treatment using 5-fluorouracil as an adjunct to free conjunctival autograft versus bevacizumab (Avastin) as an adjunct to free conjunctival autograft, via a randomised controlled prospective study. Seventy eyes of 70 patients were included...

Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration

1 June 2015 | | Retina / Uvea / Vitreous | Angiogenesis, Clinical Trial, Macula, neovascularisation, Retina
This is a sub-group study of double masked review of patients randomised to different dosages and treatment frequency compared between aflibercept and ranibizumab treatment. This is to evaluate the efficacy and safety of intravitreal aflibercept (IVT-AFL) in Japanese patients with...

Epiretinal membranes in uveitic macular oedema

1 August 2014 | | Retina / Uvea / Vitreous
Epiretinal membrane (ERM) formation in uveitic macular oedema is a fairly common structural complication of the retina. The authors describe a retrospective case series of 104 eyes of 77 patients with uveitic macular oedema from a tertiary centre. The treatment...

Retinal prosthetics: science fiction or a vision for the future?

2 December 2019 | | Retina / Uvea / Vitreous, Ophthalmology
“Is it a fact – or have I dreamt it – that, by means of electricity, the world of matter has become a great nerve, vibrating thousands of miles in a breathless point of time?” – Nathaniel Hawthorne, The House...

Getting one’s eye in

4 February 2021 | | Ophthalmology, Optometry, COVID-19
Lisette Bijma, Sister in the Eye Emergency Department at John Radcliffe Hospital, explains how COVID-19 provided a ‘baptism by fire’ and enabled fundamental and positive changes to the running of the department. Five years ago, I arrived in the UK,...

“We try our best”, but we should still be open and transparent

1 February 2018 | | Ophthalmology
In a recent discussion with colleagues, someone recognised that many, when asked what they do, say, “I am a doctor”. Rather than “I work as a doctor”. This sense of belonging, pride and duty comes with responsibility. Becoming a surgeon,...

Stem cell therapy for Parkinson’s disease: researching for an 
effective cure

1 December 2015 | | Neuro-Ophthalmology
Neurodegenerative diseases are characterised by the chronic and progressive loss of neurons, which in turn results in loss of cognitive and physical functions. The World Health Organization has estimated that the disability-adjusted life years lost from neurological disease was about...

Retinoblastoma management update (part 1): clinical features, diagnosis and genetics

1 January 2017 | | Ocular Pathology and Oncology
The first of a two part series, this article will discuss the clinical features, diagnosis and genetic aspects of retinoblastoma. Manoj Parulekar is based at Birmingham Children’s Hospital, one of the two designated national retinoblastoma and paediatric ocular oncology treatment...